Integrated HF Website on Merlin.net™ Patient Care Network
CARDIOVASCULAR
hamburger

Integrated HF Website on Merlin.net™ Patient Care Network

Integrated HF Website on Merlin.net™ Patient Care Network

PRODUCT HIGHLIGHTS

  • The CardioMEMS™ HF System is the first and only FDA-approved heart failure (HF) monitor proven to significantly reduce HF hospital admissions and improve quality of life in NYHA class III patients. When used by clinicians to manage HF, the CardioMEMS HF System is:
    • Safe and reliable - 98.6% of patients were free from device or system complications1
    • Clinically proven - reduced HF admissions by 37%1,a
    • Proactive and personalized - patient management through direct monitoring of PA pressure and titration of medications
  • The Integrated HF Website on Merlin.net™ PCN is the world’s first and only platform that integrates pulmonary artery (PA) pressure data with HF diagnostics from Implanted Electronic Devices (IEDs) such as AT/AF Burden, Percent Ventricular Pacing, Patient Activity, Day and Night Heart Rate, and VT/ VF events with antitachycardia (ATP) and shock therapies. Combining correlated HF diagnostics on a single portal allows streamlined review and comprehensive management
  • Pressure readings, trend data and pressure waveforms are intuitively displayed on the website and easily accessed by clinicians; enabling proactive and personalized patient management allowing titration of medications.
  • Patients of Interest Report summarizes all clinically actionable patients,enabling early detection of worsening heart failure and intervention. Additional notifications, triggered if pressure readings fall out of range, can also be customized and sent to any email-compatible mobile device.
  • Review and Billing Reminder feature, allows staff to track patients for regular clinical reviews, and for monthly billing of reimbursement for Physiologic Monitoring.*
  • Customized DirectCall™ Messages feature reduces staff burden by automating routine phone interactions with patients. Communications can be sent as either voice or text messages and can be customized in the clinician’s own voice for personalized interaction.
  • EHRDirect™ feature allows a one-click PDF export of the patient trends directly to their EHR record. Feature requires one time integration with clinic and EHR vendor.

ORDERING INFORMATION


1. Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomized controlled trial. The Lancet. 2011:377;658-66.

a. 37% reduction in HF hospitalizations over an average 15 months of follow-up.


Rx Only

 

Brief Summary: Prior to using these devices, please review the User’s Manual for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.

 

Indications and Usage: The CardioMEMS HF System is indicated for wirelessly measuring and monitoring pulmonary artery (PA) pressure and heart rate in New York Heart Association (NYHA) Class III heart failure patients who have been hospitalized for heart failure in the previous year. The hemodynamic data are used by physicians for heart failure management and with the goal of reducing heart failure hospitalizations.

 

Contraindications: The CardioMEMS HF System is contraindicated for patients with an inability to take dual antiplatelet or anticoagulants for one month post implant.

 

Potential Adverse Events: Potential adverse events associated with the implantation procedure include, but are not limited to the following: Infection, Arrhythmias, Bleeding, Hematoma, Thrombus, Myocardial infarction, Transient ischemic attack, Stroke, Death, and Device embolization.

 

Refer to the User’s Manual for detailed indications, contraindications, warnings, precautions and potential adverse events.

SJM-MER-0815-0057

Last Updated: January 02, 2019

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

true
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?